FATE THERAPEUTICS INC Common Stock, Capital Shares Reserved for Future Issuance
FATE THERAPEUTICS INC (FATE) had Common Stock, Capital Shares Reserved for Future Issuance of 50.61 million shares as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-02-26
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 50.61M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 43.29M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 36.04M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 38.85M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2025-12-31 | 50.61M shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 43.29M shares 10-K · filed 2026-02-26 | |
| 2023-12-31 | 36.04M shares 10-K · filed 2025-03-05 | |
| 2022-12-31 | 38.85M shares 10-K · filed 2024-02-26 | |
| 2021-12-31 | 30.63M shares 10-K · filed 2023-02-28 | |
| 2020-12-31 | 29.70M shares 10-K · filed 2022-02-28 | |
| 2019-12-31 | 27.71M shares 10-K · filed 2021-02-24 | |
| 2018-12-31 | 26.07M shares 10-K · filed 2020-03-02 | |
| 2017-12-31 | 24.40M shares 10-K · filed 2019-03-05 | |
| 2016-12-31 | 20.46M shares 10-K · filed 2018-03-05 | |
| 2015-12-31 | 4.88M shares 10-K · filed 2017-03-16 | 4.36M shares 10-K · filed 2016-03-03 |
| 2014-12-31 | 4.65M shares 10-K · filed 2016-03-03 | |
| 2013-12-31 | 3.90M shares 10-K · filed 2015-03-12 | |
| 2012-12-31 | 9.74M shares 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |